Abnormal expression of MDM-2 in breast carcinomas
- 1 June 1996
- journal article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 37 (2), 179-188
- https://doi.org/10.1007/bf01806499
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Multiple Patterns of MDM-2 Deregulation in Human Leukemias: Implications in Leukemogenesis and PrognosisLeukemia & Lymphoma, 1995
- Over‐expression of the MDM2 gene is found in some cases of haematological malignanciesBritish Journal of Haematology, 1994
- The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING fingerTrends in Biochemical Sciences, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- The p53-mdm-2 autoregulatory feedback loop.Genes & Development, 1993
- Biology of breast cancer and its clinical implicationsCurrent Opinion in Oncology, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.Journal of Histochemistry & Cytochemistry, 1991
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Prognosis in breast cancer utilizing histologic characteristics of the primary tumorCancer, 1975